Evidence map›Paper›PMID 41497435›Full record

ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2026

Real-world evaluation of ceftriaxone-related safety events: a stewardship call to action.

Kristen Paciullo, Sujit Suchindran, Leila S Hojat, Benjamin Albrecht, Sarah B Green, K Ashley Jones, Daniel J Rogers, Trinh P Vu, Lucy S Witt

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kristen PaciulloPharmacy Department, Emory Healthcare, Atlanta, GA, USA.ORCID https://orcid.org/0009-0005-8994-9590
Sujit SuchindranDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.ORCID https://orcid.org/0009-0000-6300-6491
Leila S HojatDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.ORCID https://orcid.org/0000-0003-4364-8141
Benjamin AlbrechtPharmacy Department, Emory Healthcare, Atlanta, GA, USA.
Sarah B GreenPharmacy Department, Emory Healthcare, Atlanta, GA, USA.ORCID https://orcid.org/0000-0002-5502-1533
K Ashley JonesPharmacy Department, Emory Healthcare, Atlanta, GA, USA.
Daniel J RogersPharmacy Department, Emory Healthcare, Atlanta, GA, USA.ORCID https://orcid.org/0009-0009-3968-6074
Trinh P VuPharmacy Department, Emory Healthcare, Atlanta, GA, USA.ORCID https://orcid.org/0000-0002-2885-5399
Lucy S WittDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.ORCID https://orcid.org/0000-0003-1475-6952

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A ceftriaxone safety alert prompted a review of rapid response and cardiac arrest events in relation to the timing of intravenous cephalosporin administrations across a large health system. Despite high utilization, we found a low rate of significant ceftriaxone-related adverse events with a similar incidence as other intravenous cephalosporins.

Identifiers

PMID41497435
PMCPMC12766508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.